Quantitative determination of BMS-378806
✍
Y.-J. Xue; Jing-He Yan; Mark Arnold; Dennis Grasela; Steve Unger
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 663 KB
## Abstract BMS‐378806 is a human immunodeficiency virus (HIV) entry inhibitor that is being developed for the oral treatment of HIV infection. Human plasma and urine LC/MS/MS methods have been developed and validated for the quantitation of BMS‐378806. For human plasma method, methyl __t__‐butyl e